Recent data from our laboratory suggests that sCD200 can also be detected in the serum of breast cancer and colonic cancer patients (unpublished data), consistent with the growing evidence that CD200 itself is reported to be overexpressed in a number of human cancers. The gene discussed is CD200; the disease is breast cancer.